临床肝胆病杂志2011，Vol.27Issue(5)：540-544,5.
人类免疫缺陷病毒/丙型肝炎病毒混合感染者抗丙型肝炎病毒治疗的进展
Treatment of hepatitis C virus infection in HIV/HCV co-infected patients
摘要
Abstract
Duo to increasing prevalence and complex patient management, coinfection of human immunodeficiency virus (HIV) and hepatitis C virus (HCV) is a substantial medical and public health concern. The development of highly active antiretroviral therapy (HAART) results in a dramatic decrease in morbidity and mortality among HIV-infected patients, and liver disease caused by chronic infection with HCV has become an increasingly important cause of morbidity and mortality among HIV-infected patients parenterally with HCV. Since HIV/HCV coinfection is prevalent and increases the risk of HCV-associated liver disease, effective treatment for HCV is critical for the long-term survival of this group of patients. The assessment of coinfected patients, the time of treatment, the therapy of HCV infection, monitoring of coinfected patients before and during therapy of HCV infection, evaluation of the response to treatment, the caution during treatment are stated bfiefly.关键词
HIV感染/肝炎,丙型/肝炎病毒属/重叠感染Key words
HIV infections/ hepatitis C/ hepacivirus/ supefinfection分类
医药卫生引用本文复制引用
田地,徐小元..人类免疫缺陷病毒/丙型肝炎病毒混合感染者抗丙型肝炎病毒治疗的进展[J].临床肝胆病杂志,2011,27(5):540-544,5.基金项目
国家自然科学基金(30771906) （30771906）
高等学校博士学科点专项科研基金(20090001110081) （20090001110081）
国家科技重大专项(2008ZX10002-013) （2008ZX10002-013）
